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Abstract
Background: The current food pyramid guidelines have been criticized because of their
complexity and the knowledge required for users to understand the recommendations.
Simplification of a dietary message to focus on a single key aspect of dietary quality, e.g., fiber intake,
may make the message much easier to comprehend and adhere, such that respondents can achieve
greater weight loss, better dietary quality and overall metabolic health.
Methods and design: This is a randomized controlled clinical trial with two equal sized arms. In
total, 240 obese adults who meet diagnostic criteria for the metabolic syndrome will be
randomized to one of the two conditions: 1) a high fiber diet and 2) the American Heart
Association (AHA) diet. In the high fiber diet condition, patients will be given instruction only on
achieving daily dietary fiber intake of 30 g or more. In the AHA diet condition, patients will be
instructed to make the several dietary changes recommended by the AHA 2006 guidelines. The
trial examines participant weight loss and dietary quality as well as changes in components of the
metabolic syndrome, inflammatory biomarkers, low-density lipoprotein cholesterol levels, insulin
levels, and glycosolated hemoglobin. Potential mediators, i.e., diet adherence and perceived ease of
the diet, and the intervention effect on weight change will also be examined.
Discussions: The purpose of this paper is to outline the study design and methods for testing the
simple message of increasing dietary fiber. If the simple dietary approach is found efficacious for
weight loss; and, improves dietary quality, metabolic health, and adherence, it might then be used
to develop a simple public health message.
Trial registration: NCT00911885
Background
Metabolic syndrome affected nearly 27% of US adults in
2006, and due to rising obesity rates, the prevalence of
metabolic syndrome is likely much higher in 2009. Meta-
bolic syndrome is strongly associated with poor dietary
quality [1], and treating it is one of the keys to the preven-
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tion of cardiovascular disease (CVD) [2,3] and diabetes
[4,5]. Research is needed on interventions that effectively
treat metabolic syndrome, preventing its advance to the
physical, mental, and financial costs of CVD and diabetes.
The impact of public health campaigns is maximized
when a health message is simple and easy to understand
[6]. Dietary guidelines like those put forth by the Ameri-
can Heart Association (AHA), US Department of Agricul-
ture (USDA), and the American Diabetes Association
(ADA) [7-9] are based on research and are in the interest
of public health but are also complex involving multiple
macronutrients, each with differing recommended por-
tion sizes and daily servings. A healthy diet is key to CVD
and diabetes prevention but we are lacking a simple, effec-
tive public health message to improve the American diet.
A simple dietary message is only possible to the extent
that one area of diet is identified that, on the one hand,
has a strong impact on overall dietary quality and disease
prevention, and on the other hand, is associated with
good adherence and acceptability. One possible area of
diet that could meet these two criteria is dietary fiber. Die-
tary fiber has been demonstrated to be a useful compo-
nent of weight loss and weight loss maintenance [10-12]
and it acts directly on several aspects of the metabolic syn-
drome including decreasing waist circumference and
body weight, glucose and lipid homeostasis, and improv-
ing hypertension and insulin control [13,14].
Body weight and waist circumference
Observational and review studies have indicated an
inverse relationship between dietary fiber intake, body
weight and waist-to-hip ratio ([10-12] with several rela-
tively short-term intervention studies further supporting
the relationship between a high fiber diet and moderate
reductions of body weight and waist circumference [15-
17]. Epidemiologic studies support a strong negative asso-
ciation between dietary fiber intake and obesity. However,
a limited number of clinical trials have been conducted
directly associating a simple dietary fiber message with
metabolic components, including the mechanism by
which fiber acts. Howard and colleagues concluded from
12 published intervention studies that under conditions
of fixed energy intake, an increase in dietary fiber intake
increased post-meal satiety and decreased subsequent
hunger [10]. When energy intake is ad libitum, increasing
consumption of dietary fiber is associated with weight
loss via a decrease in energy intake. A review by Lairon
also supports these results [12]. It is proposed that high-
fiber foods promote satiety through delayed gastric emp-
tying, increased food volume, and increased chewing,
which attenuates the return of hunger [18,19], and leads
to decreased energy intake. In fact, Pereira and colleagues
reviewed 27 clinical studies and concluded that most
studies showed that an increased fiber intake correlates
with a reduced energy intake of 10% [18]. In addition,
fiber decreases the absorption efficiency of the small intes-
tine ([11].
Insulin resistance and hypertension
An increased intake of total fiber is inversely associated
with markers of insulin resistance and reduced diabetes
risk [20-22]. The Insulin Resistance Atherosclerosis Study
showed that dietary fiber was significantly associated with
insulin sensitivity, fasting insulin, body mass index
(BMI), and waist circumference [22]. Similarly, in the
Inter99 study, intake of dietary fiber was inversely associ-
ated insulin resistance estimated using the homeostasis
model assessment of insulin resistance (HOMA-IR) [21].
In addition, soluble dietary fiber has been reported to
reduce postprandial glucose levels and to improve insulin
sensitivity [23,24]. These findings support the recommen-
dation to increase intake of fiber-rich carbohydrates to
prevent insulin resistance [25]. Clinical trials indicate that
a diet high in fiber decreases blood pressure in hyperten-
sive and obese individuals [26,27]. Since insulin resist-
ance with compensatory hyperinsulinemia has been
named a major pathogenic vehicle for the development of
hypertension [28], reducing insulin resistance through
increasing dietary fiber intake may help treat or prevent
hypertension. In addition, increasing dietary fiber intake
promotes weight loss and deters weight gain, both of
which would likely have a large impact on the prevention
and burden of hypertension.
Inflammation biomarkers
Observational studies draw a significant link between die-
tary fiber intake and reduced levels of C-reactive protein
(CRP) [29-32]. In a small clinical trial of 28 subjects, King
and colleagues demonstrated that increasing fiber low-
ered the levels of CRP [33]. We have discussed four possi-
ble mechanisms between dietary fiber and inflammation
in our two recent publications [31,32]. First, dietary fiber
decreases lipid oxidation, which in turn is associated with
decreased inflammation [34]. Second, dietary fiber sup-
ports normal bowel flora as part of an optimal intestinal
environment, which helps to prevent inflammation [34].
Third, dietary fiber may inhibit inflammation through its
beneficial effects on glycemic control [35,36]. Finally,
diets high in fiber may increase plasma adiponectin con-
centrations in diabetic patients: adiponectin has been
found to have profound anti-inflammatory effects [37].
Glycemic and lipid control
In a crossover design of 11 patients with metabolic syn-
drome, patients supplemented a high-carbohydrate diet
with soluble fiber for 3 weeks [38]. Results indicate that a
high fiber diet improves glycemic control, total and LDL
BMC Medical Research Methodology 2009, 9:87 http://www.biomedcentral.com/1471-2288/9/87
Page 3 of 10
(page number not for citation purposes)
cholesterol, while triglycerides and HDL cholesterol
remained unchanged.
Our preliminary pilot study data suggest that simply
focusing on increasing dietary fiber is equivalent or better
than a low-saturated fat message at inducing clinically sig-
nificant improvement of dietary quality, and may be supe-
rior for long-term adherence [39]. Participants were
randomized to receive either a simple message to increase
fiber intake, a simple message to reduce saturated fat
intake, or a combination to increase fiber and reduce sat-
urated fat. At 3 months, participants in the fiber arm
increased their fiber intake by 44% and vicariously
reduced their saturated fat intake by 25%. Participants in
the saturated fat arm reduced their saturated fat intake by
25% but their fiber intake only changed by 2%. These
changes were maintained at 6 months. The dual message
arm did not show any significant improvement over the
dietary fiber arm alone. Patients in the high fiber group
lost 7 lbs at 3 months, and 10 lbs at 6 months. The single
message of increasing dietary fiber might be more accept-
able by encouraging increases in intake of particular foods
as opposed to depriving messages about eliminating
foods. When asked at 3 months about confidence in
adhering to the study diet, 85% of participants in the high
fiber group felt very or extremely confident they could
adhere to the recommendation, while only 50% of partic-
ipants in the decrease saturated fat condition and 40% of
participants in the combination condition felt this way.
We hypothesize that a simplified dietary recommenda-
tion focusing on a single aspect of dietary quality - fiber
intake - will facilitate weight loss, and improve both met-
abolic health and overall dietary quality. Such a simplified
dietary advisory is easier to follow, and may have benefi-
cial collateral effects on other areas of diet (e.g., reduced
caloric and saturated fat intake, and increased intake of
protective foods). Such a simple message, if found effica-
cious for weight loss, metabolic health and dietary quality
in a clinical setting, might then be an ideal message for
public health settings.
Research Goals
The overall goal of the present study is to compare the effi-
cacy of two dietary intervention approaches on weight
loss and improving dietary quality among patients with
the metabolic syndrome. One approach is complex and
the other is simple. The two approaches are: 1) the AHA
Dietary Guidelines [40] that is currently recommended to
patients with the metabolic syndrome [41,42]; and 2) a
high fiber diet that provides instruction on a single area of
diet, fiber. Secondary research goals include examining
changes in components of the metabolic syndrome,
inflammatory markers, low-density lipoprotein (LDL-C)
cholesterol levels, insulin levels, and glycosolated hemo-
globin (HbA1c). We hypothesize that the high fiber con-
dition will significantly improve overall diet quality and
metabolic health over the AHA condition. Additionally,
potential mediators (i.e., adherence and perceived ease of




The study protocol was approved by the University of
Massachusetts Medical School's (UMMS) Institutional
Review Board. Two hundred forty adults (50% female)
who meet diagnostic criteria for the metabolic syndrome
will be randomized to the high fiber condition or the AHA
diet condition. The study was funded by the National
Heart, Lung and Blood Institute.
Subject Eligibility Criteria
To be eligible for the study, an individual must: 1) Meet
diagnostic criteria for the metabolic syndrome [43]; 2) Be
interested in losing weight and have a BMI 30-40 kg/m2;
3) Be between 21 to 70 years old; 4) Have a telephone in
the home or easy access to one; 5) Provide informed con-
sent; 6) Have physician approval to participate in the
study; 7) Be a non-smoker (given nicotine's effect on
weight suppression, on HDL-C, and smoking cessation's
effect weight gain); and, 8) Be able to speak and read Eng-
lish.
An individual will be excluded from participation if he/
she:1) Has clinically diagnosed diabetes, or a fasting
blood sugar of ≥ 126 mg/dl; 2) Had an acute coronary
event within the previous 6 months; 3) Is pregnant or lac-
tating; 4) Is a woman with polycystic ovary syndrome
[44]; 5) Plans to move out of the area within the 12-
month study period; 6) Has a diagnosis of a medical con-
dition that precludes adherence to study dietary recom-
mendations (e.g., Crohn's disease, ulcerative colitis, active
diverticulitis, renal disease); 7) Has elevated depression or
suicidal ideation; 8) Is following a low-carbohydrate,
high-fat dietary regimen such as the Atkins' Diet [45]; 9)
Is participating in any current weight loss program; 10)
Has had bariatric surgery or is currently using weight loss
medication; or, 11) Has been diagnosed with an eating
disorder (bulimia nervosa or binge eating).
Recruitment
Study recruitment began in May 2009. Recruitment strat-
egies include: posting study recruitment fliers at the Uni-
versity of Massachusetts Medical School (UMMS), local
public libraries and churches; announcements on the
UMMS intranet; recruitment ads in the local newspapers
and on Craigslist; and targeted direct mailings. All IRB
approved posters and advertisements include a phone
number that individuals can call. Potential subjects
BMC Medical Research Methodology 2009, 9:87 http://www.biomedcentral.com/1471-2288/9/87
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responding to study advertisements receive an explana-
tion of the study and are screened via telephone using a
brief questionnaire focused on inclusion and exclusion
criteria. This information is retained in a database with
Lotus Notes/IBM tracking system software (Lotus Notes
R5.0.11®) developed specifically for this study. When an
individual is found to be pre-eligible for the study and
expresses interest in participating, a screening appoint-
ment is then scheduled.
The University is currently updating its clinical data sys-
tem and once it is complete, we will be able to identify
patients who are eligible using a primary care patient pop-
ulation database. A HIPAA-IRB waiver will be obtained to
identify eligible patients.
Study Measures at Screening Visit, Baseline Visit and 
Patient Follow-up
At the screening visit, a screening consent form is reviewed
and signed. The Cholestech LDX System™ is used to meas-
ure HDL-C, triglycerides, and glucose from a fasting fin-
gerstick with results produced within 10 minutes.
Individuals are asked to fast 12-hours prior to the
appointment. Patients have their height and weight meas-
ured in stocking feet via an electronic digital scale (Scale-
Tronix, Carol Stream, Illinois, Model 5002 Stand-On
Scale). Waist is measured twice at the narrowest part of the
torso (or a site between the lower rib and crest of the hip-
bone). Blood pressure is also measured two times: ini-
tially after sitting quietly for 10 min, then again after 2
minutes using a Dinamap XL ® automated BP monitor
(Critikon). The Center for Epidemiological Studies-
Depression Scale (CES-D)[46,47] is administered to
assess for depression. Individuals with CES-D >= 21, indi-
cating severe depressive symptoms [48], are excluded
from participation. Medical clearance is then requested
from the primary care physician, and individuals found to
be eligible are invited back for a baseline visit.
At the baseline visit, a second study consent form is
reviewed with the research assistant and signed. A fasting
blood sample, anthropometric measures, and medication
and supplement information are collected, which will
again be assessed at the 3-, 6-, and 12-month visits. A
questionnaire packet assessing demographic information
and psychosocial variables is completed at baseline, 3-, 6-
and 12-month visits. Three 24-hour diet and physical
activity recalls are collected within a three-week window
at baseline, 6- and 12-month visits to determine individ-
ual dietary and physical activity change, and one 24-hour
recall is collected at 3 months to determine group differ-
ences. The 3-month visit assessment will measure short-
term changes in body weight and metabolic syndrome
indicators, however, inflammatory markers, insulin, and
HbA1c will not be measured. Table 1 includes a complete
list of study measures and the timing of these measures.
Patients receive a stipend of $10 at baseline and the 3
month assessment; $20 at the 6-month assessment; and
$40 at the 12 month assessment.
Randomization
After providing informed consent and completing the
baseline assessment, participants are randomized to one
of the two diet conditions. Participants are stratified by
gender, age (in deciles), and BMI categories (30-34.9, and
>= 35-40 kg/m2). Within each strata, participants are ran-
domized to the two conditions in randomly permuted
blocks of size 3 and 6 using the ralloc program in Stata
[49] to ensure that the distributions of gender, age, and
BMI are similar between two conditions. The randomiza-
tion is carried out by the project director who does not
interact with participants.
Intervention
The proposed intervention will consist of 5 sessions dur-
ing a 3-month intensive phase (1 group session in the 1st
month, one individual and one group session during the
2nd month, and biweekly sessions in month 3), and a 9-
month maintenance phase of 5 group sessions (during the
4th, 5th, 7th, 9th, and 11th months) and one individual ses-
sion (at the 12th month) for a total of 11 sessions. Individ-
ual sessions will be offered at different days and times to
accommodate participant schedules.
Patients will have received a diet manual at the first group
visit, containing intervention contents by session, home
activity worksheets, resources, recipes, and selected menus
with nutrition information from restaurants (either AHA
or dietary fiber oriented). At the next individual nutrition
consultation, an assessment of lifestyle, current dietary
habits, challenges to dietary changes and specific nutri-
tion needs, and individualized study goals are reviewed by
a registered dietitian. Patients begin tracking their dietary
intake in preparation for the third group visit. All group
and individualized sessions will be conducted by a regis-
tered dietitian initially randomly assigned and trained to
the study condition, and will focus on reviewing progress
and setting new goals to support achievements. Each ses-
sion will address any challenges to adherence and facili-
tate progress toward the patient's new eating style. As self-
monitoring can enhance self-control and facilitate prob-
lem solving, patients will self-monitor their intake with a
food diary, or by using an electronic tracking system. This
will facilitate the counting of fiber grams in the high fiber
condition, or other food components in the AHA condi-
tion. The dietitian will review and return food diaries to
assist patients with meeting dietary goals. Dietitian pro-
viders are trained in a patient-centered counseling model
and strategies from social-cognitive theory to activate
patients to take action and responsibility for changing
BMC Medical Research Methodology 2009, 9:87 http://www.biomedcentral.com/1471-2288/9/87
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their dietary lifestyle to meet the goal prescribed [50]. All
but the first group session will last 1 hour, and will
include weighing the patient, a light snack of study appro-
priate foods, and other tools and methods (The first ses-
sion lasts 1.5 hours). The first and last individual visits
will be 1 hour, and 30 minutes respectively.
Group sessions will target individual food choices, envi-
ronmental and social influences to dietary intake, lifestyle
challenges, and problem-solving techniques in a support-
ive group format targeting dietary changes over the longer
term. Significant others are invited to attend each session
and to sign consent to have their weight tracked. Partici-
pants unable to attend a session will be offered brief
make-up sessions, either by telephone, or in person and
are mailed the materials from the missed session.
High Fiber Diet Condition
Participants randomized to the high fiber condition
receive instruction on how to gradually increase their die-
tary fiber intake to ≥ 30 g fiber per day, with a correspond-
ing increase in non-caloric fluids as necessary to alleviate
any gastrointestinal discomfort that may occur because of
the increase in dietary fiber [51,52]. The multiple benefits
of increasing dietary fiber will be outlined in an engaging,
experiential format, with tasting of high fiber foods pro-
vided. Participants are encouraged to obtain fiber from a
variety of high fiber foods, so they are not relying upon
one type of food or fiber (such as high fiber bars or sup-
plements), with a variety of recipes and substitutions sug-
gested allowing for individual tastes, tolerance, and
preferences. Participants receive written materials on the
fiber content of different foods so they can choose from a
vast list of foods that include both soluble and insoluble
fiber, such as legumes, barley and other whole grains,
nuts, seeds, fruit and vegetables. Self-monitoring will
increase awareness and knowledge of intake to attain fiber
goals. Participants will be working closely with the dieti-
tian to ameliorate any intestinal discomfort (bloating,
gas) associated with increasing fiber intake.
AHA Diet Condition
Participants randomized to the AHA condition receive
step-by-step instruction on the multiple components of
dietary change, which includes a diet rich in vegetables
and fruits; whole-grains, high-fiber foods; fish, especially
oily fish at least twice a week; lean animal and vegetable
proteins; learn to distinguish types of fats and oils; mini-
mize intake of beverages and foods with added sugars;
choose and prepare foods with little or no salt; and con-
Table 1: Measurement Schedule
Timepoint
Measure Baseline 3 mos 6 mos 12 mos
Physiological measures:
• Blood glucose ● ● ● ●
• Glycosylated hemoglobin ● ● ●
• Blood pressure ● ● ● ●
• Insulin ● ● ●
• Inflammatory markers (hs-CRP, Il-6, TNF-a) ● ● ●
• Serum lipids ● ● ● ●
• Body habitus measures (height, weight, and waist circumference) ● ● ● ●
Diet, physical activity, medication use, and psychological variables:
• 24-hr dietary recall (3 times at each timepoint) ● ● ● ●
• 24-hr physical activity recall (3 times at each timepoint except 1 recall only at 3 mths) ● ● ● ●
• Medication use ● ● ●
• Depressive symptoms (CES-D) ● ● ●
• Quality of life (SF-36) ● ● ●
• Social desirability ●
Patient Characteristics
• Socio-demographic variables ●
• Medical history ●
Process Variables
• Retention rate ●
• Session attendance ●
• Intervention acceptability ● ●
• Self-efficacy, attitudes, social support, perceived barriers related to dietary changes ● ● ● ●
BMC Medical Research Methodology 2009, 9:87 http://www.biomedcentral.com/1471-2288/9/87
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sume moderate to no alcohol intake. A target of 50-55%
of calories from carbohydrate, 15-20% from protein, and
30-35% of calories from fat (saturated fat limited to <7%
of energy, trans-fat to <1% of energy, cholesterol <300 mg/
day,) will be suggested. Calorie goals will be calculated
and provided to patients by estimating the daily calories
needed to maintain the participant's starting weight and
subtracting 500-1,000 calories/day (depending on initial
body weight and level of activity) to achieve a 1-2 pound
per week weight loss (i.e., (starting weight × 12) - 500
kcal). Self-monitoring will increase awareness and knowl-
edge of dietary intake and progress toward AHA goals.
Physical Activity
We acknowledge the beneficial effect of physical activity
on weight loss and most metabolic syndrome compo-
nents (elevated blood pressure, insulin resistance, and
central obesity). However, the present study was designed
to assess the effect of a simple dietary recommendation
against the AHA diet on weight loss, overall dietary quality
and factors of the metabolic syndrome. Therefore, we
focus exclusively on dietary modifications during the ses-
sions.
Safety Precautions
Participants in both arms of the study will be advised to
increase fiber slowly, and told to increase fluids to mini-
mize digestive discomfort. Most participants will tolerate
an increase in fiber, but some participants may experience
gas, bloating, and changes to bowel habits. Participants
will be monitored and encouraged to speak about any
physiological or psychological difficulties of dietary
change to allow the dietitian to assist with transitions to a
higher fiber diet or AHA diet, both individually and as
part of the group sessions. Over a short period of time
(about 1 month or less), most digestive systems will
adjust to an increase in dietary fiber. Occasionally, partic-
ipants are unaware of diverticulosis, and dietary changes
may trigger active disease. Participants with active diver-
ticulitis and other gastrointestinal disease are ineligible.
Additionally, there may be financial costs associated with
making dietary changes, as the participants will be pur-
chasing different foods.
Training of Intervention Team Providers
All providers will be trained in the intervention delivery
models relevant to their randomly assigned condition and
will not be trained or have access to training materials for
the other condition. Ample opportunities will be pro-
vided for developing and practicing the counseling skills
to ensure fidelity to the intervention manual.
Four separate 2-hour training sessions are held. The train-
ing team includes the PI, a senior dietitian, and a clinical
health psychologist. Dietitians will be oriented to the
intervention manual for their condition, discuss difficult
patient situations, review quality control procedures, and
practice counseling skills. The team will work with each
dietitian in typical patient interaction simulations. Lastly,
each dietitian will present a selected "mock" session as a
seminar at UMMS campus for faculty and students.
In order to provide the dietitian with feedback regarding
their knowledge of the different interventions, all sessions
are digitally recorded, with the senior dietitian listening to
each of the first 5 sessions in order to provide feedback,
and then 10% of sessions thereafter. Dietitian's knowl-
edge, counseling and teaching skills will meet standards
outlined on a certification checklist. Dietitians will attend
regular supervision meetings with the senior dietitian, the
clinical health psychologist, and PI to discuss study topics,
fidelity to protocol, and group concerns.
Treatment Fidelity
Because both conditions involve dietary interventions
that have some subtle but very important differences, con-
tamination and treatment fidelity will be closely moni-
tored. Different dietitian providers are employed for each
condition to prevent drift and/or contamination between
conditions. During training and supervision, dietitians
will be trained to handle situations when patients want to
discuss topics not on protocol, with particular emphasis
in the increase fiber condition to simply focus on consum-
ing a variety of high fiber foods, without attention to dis-
tinction of calories, fats, carbohydrates or protein.
The purpose of fidelity monitoring is two-fold. First, we
will ensure that treatment objectives for each condition
are met at each session. Second, we will ensure that treat-
ment objectives specific to one condition are not being
met in the other condition (i.e., contamination). Two sets
of treatment fidelity checklists (one arm-specific provider
checklist and one auditor checklist) have been developed.
Dietitians will complete the provider checklist after each
session. A 10% randomly selected sample of the audio-
recorded sessions will be reviewed by the senior dietitian
and clinical psychologist. Each will then complete the
Auditor Checklist corresponding to that session. When a
session is reviewed with less than 85% of treatment-spe-
cific objectives met and/or any evidence of contamination
(>0% other condition objectives met), the auditor will
deliver that information to the PI who will then review the
treatment objectives for that session with the counselor
and remediate training as needed. This process will be
ongoing throughout all treatment waves so that counselor
drift can be swiftly corrected.
Sample Size Consideration
The required numbers of patients for each arm were based
on the primary outcome measure: change in body weight.
BMC Medical Research Methodology 2009, 9:87 http://www.biomedcentral.com/1471-2288/9/87
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Sample size was calculated using the method developed
by Frison and Pocock [53] and implemented in Stata SE
10 (College Station, Texas, USA). Parameters used in sam-
ple size calculations were estimated in our pilot trial and
historical data from metabolic patients in our clinics, and
we assumed complete randomization of the study sub-
jects to each treatment arms. With 95 complete cases per
arm, the hypothesized difference in change in body
weight (3.5 lbs) between the arms can be detected with
>80% power at 5% significance level.
Considering possible attrition rate of 20%, the number of
subjects in each arm should be not less than 120 subjects.
Thus, a total of 240 patients will be enrolled in the study.
Statistical Analytic Approach for Primary Aim
The high fiber condition is hypothesized to induce greater
weight loss than the AHA condition. We will evaluate the
intervention effects on change in body weight using gen-
eral and generalized linear latent and mixed models
(GLLAMM) that have been implemented in Stata SE 10
[54,55]. The commonly used linear mixed models are a
subgroup of GLLAMM. In the analysis, each patient is
assumed to be independent. First, we will carefully evalu-
ate the covariance structure of the outcome variables
across time points, and test whether intervention may
induce changes in variability in the outcomes. Proper cov-
ariance structure will be identified and prescribed in the
final analysis. The participant identifier will be included
as random effect, time and group as fixed effect. Treatment
effect will be tested using time*group interactions in the
models.
The analysis will adjust for potential confounders for
weight change, including age, gender, baseline BMI, mar-
ital status, education attainment, physician advice regard-
ing weight loss and other nutritional advice exposure
prior to and during the trial. We also will evaluate the pos-
sible interactions between the intervention indicator and
these patient's attributes to assess the presence of differen-
tial intervention effects among these subgroups. Session
attendance will also be included in the models to deter-
mine whether this is a dose-response relationship
between number of session attended and the extent of
weight loss. Statistical approaches to secondary outcomes
are very similar, and thus not discussed in detail.
Project Management and Participant Tracking
Under the direct leadership of the project director, project
staff will be responsible for: 1) tracking patients to ensure
that all necessary data are collected in a timely fashion; 2)
assist with developing monitoring reports; 3) providing
timely and relevant feedback to the leadership regarding
the accuracy of data; and, 4) the day-to-day functioning of
the study across all 10 waves of recruitment, intervention
and assessment. The tracking system used for monitoring
patient activities and providing necessary prompts based
on a communication system using Lotus Notes from IBM
(Lotus Notes R5.0.11®). Multiple levels of password pro-
tection are utilized to ensure data security. The tracking
system will facilitate timely scheduling of assessments and
identification of completed assessments.
Data Entry and Management of Data Files
All data are entered into computerized data files (Epi Info
for double-entry and Lotus Notes for patient tracking). All
data entry systems employ automatic checks for values
that are out of range or represent errors of faulty logic.
Each patient will be assigned a study ID number to ensure
confidentiality.
The data manager/programmer, under the supervision of
the PI and project biostatistician will: 1) train project staff;
2) monitor all data collection protocols to assure compli-
ance; 3) generate monitoring reports; 4) provide feedback
regarding data accuracy and precision; and 5) implement
variable edit checking. The study biostatistician will have
responsibility for structuring the primary datasets, data
linking procedures, variable naming conventions, code-
books, and documentation. Frequent exploratory analy-
ses and range/value checking protocols will detect
erroneous values. Data from each source will be merged
using study-specific patient identification numbers and
will be transferred to Stata SE 10 data files for analysis. All
patient identifiers will be removed from analytic datasets.
All database files will be stored on a password protected
network drive with firewall protection that is managed by
UMMS Information Service. All project-related data files
will be automatically backed up daily per UMMS data
safety protocol. A study directory will be established as the
central repository for all final Stata datasets. Only the
authorized project staff will have access to the databases.
Project staff are prohibited to download data files with
patient identifies to local drives unless authorized by the
PI and Project Director.
Discussion
Identifying a simpler dietary recommendation for weight
loss and improving both dietary quality and metabolic
health may demonstrate potential for a simple public
health message to impact the metabolic syndrome and its
sequelae of chronic disease. In a randomized clinical trial
design, the present study will compare the efficacy of two
intervention approaches to dietary change for CVD and
diabetes prevention among persons with metabolic syn-
drome.
The prevalence of the metabolic syndrome is 26.7%
according to the NHANES 1999-2000 survey of U.S.
adults. Using 2000 census data, about 47 million US resi-
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dents have the metabolic syndrome [4]. The metabolic
syndrome is a harbinger of type 2 diabetes and CVD, both
leading causes of mortality in the US. Lifestyle change is
the cornerstone of recommended care for patients with
metabolic syndrome [40,43].
Zivkovic and colleagues, in a comparative review of cur-
rent dietary guidelines, diets, and dietary components,
suggested that the AHA dietary recommendations are suit-
able for patients with the metabolic syndrome [41], with
a similar suggestion made in a literature review, by Felde-
isen and Tucker [42]. Theoretically, perfect adherence to
the AHA diet would result in very high dietary quality and
would impact components of the metabolic syndrome,
however, progress in following this diet has been less than
stellar. The composite of 13 different recommendations
may be too complex for patients to understand and follow
[6,9], limiting the benefits. The current study hypothe-
sizes that it may not be necessary to give people guidance
on every area of diet for diet quality to improve, because
change in one area often result in changes in other areas
of diet, both intentionally and unintentionally.
In a editorial on role of diet on insulin sensitivity and dia-
betes prevention, Xavier Pi-Sunyer recommended concen-
trating on educating the public to increase dietary fiber
intake because "there is excellent evidence that the higher-
fiber foods, made up of whole grains, fruits, and vegeta-
bles, will do people good"[20]. Although evidence dem-
onstrates a link between dietary fiber, body weight and
metabolic syndrome, more research is necessary to trans-
late epidemiologic evidence and recommendations into
effective clinical practice. To further this goal, the pro-
posed study will measure inflammatory markers to eluci-
date possible mechanisms by which dietary fiber alone
can impact metabolic syndrome, as compared to the more
complex approach currently recommended by the AHA.
In addition to improving markers of metabolic syndrome,
high intake of dietary fiber is associated with improved
diet quality. In an observational study, Kranz and col-
leagues found that children in the high-fiber quartile con-
sumed diets with higher nutrient density and increased
number of servings from Food Guide Pyramid food
groups (i.e.; fruit and vegetables, whole grains) [56]. Con-
sumption of whole grain carbohydrates increased and the
percentage of calories from fat significantly decreased;
intake of micronutrients including iron, folate, vitamin A,
and vitamin C increased significantly across quartiles of
fiber consumption; and mean calcium intake also
increased. In a review article, Lairon concluded that fiber-
rich foods also have a number of bioactive phyto-chemi-
cals that may have an additional beneficial role [12]. We
analyzed the dietary quality of popular dietary plans and
concluded that patients can lose weight with most dietary
plans in the short term, but when the goal is to change the
lifestyle and maintain changes, it is important to consider
whether or not the diet is healthful for cardiovascular con-
cerns over the long-term [57]. This is especially true for
patients with metabolic syndrome. Our findings suggest
that the highest fiber diets were the best in terms of diet
quality.
By focusing on a single aspect of diet - increasing dietary
fiber - patients may choose foods of higher dietary quality
(whole grains, fruit, vegetables, legumes) without feeling
overwhelmed by the complexity of multiple dietary
changes. Increased dietary quality and fiber intake were
inversely association with body weight in previous studies
([10-12,58]. Our preliminary work reveals that increases
in fiber may be associated with changes in other aspects of
diet (e.g., reducing saturated fat intake), thereby affecting
dietary quality even beyond the simple increase in fiber
intake. We concluded from our pilot study that it may not
be necessary to give instruction on several areas of the diet
because correct simple changes might beneficially influ-
ence other areas of diet [39]. Simplifying diet changes,
increasing fiber intake appears to have excellent effects on
weight and factors of the metabolic syndrome.
Conclusion
Data from the present study will enhance our understand-
ing of the overall impact of a simple dietary change on
metabolic health and diet. If the simple fiber approach is
successful, it may then be used to develop a simple public
health message.
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